SEC 13F Intelligence

Kinloch Capital, LLC / ABBV

Kinloch Capital, LLC’s Abbvie Inc Position

Does Kinloch Capital, LLC own Abbvie Inc (ABBV)? Yes24.9K shares worth $5M (+2.21% of its 13F portfolio) as of Q1 2026, up from 24.2K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
24.9K
% of Portfolio
+2.21%
Quarters Held
22
currently held

Position History ABBV

Reported value by quarter
Q4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $2MQ3 ’21: $2MQ3 ’21Q4 ’21: $4MQ1 ’22: $5MQ2 ’22: $5MQ2 ’22Q3 ’22: $4MQ4 ’22: $5,241Q1 ’23: $3,009Q1 ’23Q2 ’23: $3MQ3 ’23: $3MQ4 ’23: $3MQ4 ’23Q1 ’24: $3MQ2 ’24: $3MQ3 ’24: $4MQ3 ’24Q4 ’24: $3MQ1 ’25: $5MQ2 ’25: $4MQ2 ’25Q3 ’25: $6MQ4 ’25: $6MQ1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202624.9K$5M+2.21%
Q4 202524.2K$6M+2.38%
Q3 202524.5K$6M+2.48%
Q2 202524.2K$4M+2.09%
Q1 202523.3K$5M+2.34%
Q4 202419.3K$3M+1.72%
Q3 202418.5K$4M+1.78%
Q2 202419.0K$3M+1.70%
Q1 202419.1K$3M+1.78%
Q4 202317.8K$3M+1.75%
Q3 202318.3K$3M+1.71%
Q2 202318.6K$3M+1.49%
Q1 202318.9K$3,009+1.76%
Q4 202232.4K$5,241+3.05%
Q3 202231.5K$4M+2.79%
Q2 202231.3K$5M+3.09%
Q1 202230.2K$5M+2.93%
Q4 202129.0K$4M+2.43%
Q3 202121.8K$2M+1.66%
Q2 202119.6K$2M+1.58%
Q1 202119.2K$2M+1.59%
Q4 202017.9K$2M+1.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kinloch Capital, LLC’s full portfolio or all institutional holders of ABBV.